apomorphine has been researched along with andrographolide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, SP; Barber, SC; Bennett, E; Brancale, A; Coluccia, A; Gardner, I; Grierson, AJ; Heath, PR; Higginbottom, A; Kirby, J; Mead, RJ; Patel, N; Shaw, PJ | 1 |
1 other study(ies) available for apomorphine and andrographolide
| Article | Year |
|---|---|
S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antioxidant Response Elements; Apomorphine; Brain; Cells, Cultured; Diterpenes; Fibroblasts; Humans; Mice; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction | 2013 |